GYRE
Gyre Therapeutics, Inc.$5.97-0.09 (-1.40%)Prev Close$6.06·MCap$610.1M·P/E359.56·Vol57.1K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
7
$809.1K
◆
Net Activity
Net Seller
$809.1K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Gyre Therapeutics, Inc. (GYRE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 7 insider sales totaling $809.1K. The most recent insider transaction was by Ye Weiguo (officer: Chief Operating Officer), who sold $128.9K worth of shares on Jun 11, 2026. Gyre Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $610.1M.
GYRE Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 20,918 | $6.16 | $128.9K | 700,000 |
| Jun 8, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 34,976 | $6.25 | $218.6K | 700,000 |
| May 27, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 7,500 | $6.09 | $45.7K | 700,000 |
| May 22, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 12,820 | $6.15 | $78.8K | 700,000 |
| May 20, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 9,320 | $6.38 | $59.4K | 700,000 |
| May 18, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 28,680 | $6.79 | $194.8K | 700,000 |
| May 7, 2026 | Luo Ying | director, officer: Chief Executive Officer | Sell | 10,315 | $8.04 | $82.9K | 2,575,362 |
| May 27, 2025 | Ma Songjiang | President | Sell | 2,558 | $10.23 | $26.2K | 0 |
| May 22, 2025 | Ma Songjiang | President | Sell | 2,182 | $10.91 | $23.8K | 0 |
| May 20, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.04 | $44.2K | 0 |
| May 16, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.21 | $44.8K | 0 |
| May 14, 2025 | Ma Songjiang | President | Sell | 2,020 | $10.69 | $21.6K | 0 |
| May 12, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.97 | $43.9K | 0 |
| Mar 21, 2025 | Ma Songjiang | President | Sell | 174 | $10.00 | $1.7K | 0 |
| Mar 19, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.11 | $40.4K | 0 |
| Mar 17, 2025 | Ma Songjiang | President | Sell | 2,242 | $11.89 | $26.7K | 0 |
| Mar 13, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.06 | $48.2K | 0 |
| Mar 11, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.57 | $46.3K | 0 |
| Mar 7, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.19 | $40.8K | 0 |
| Mar 5, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.89 | $43.6K | 0 |
| Mar 3, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.05 | $44.2K | 0 |
| Feb 27, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.37 | $45.5K | 0 |
| Feb 25, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.50 | $46.0K | 0 |
| Feb 21, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.30 | $45.2K | 0 |
| Feb 19, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.22 | $48.9K | 2,869,260 |
| Feb 14, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.59 | $46.4K | 2,873,260 |
| Feb 12, 2025 | Ma Songjiang | President | Sell | 3,878 | $11.72 | $45.4K | 2,877,138 |
| Feb 11, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.51 | $50.0K | 2,881,138 |
| Feb 6, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.01 | $48.0K | 2,885,138 |
| Feb 4, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.49 | $46.0K | 2,889,138 |
| Jan 31, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.40 | $45.6K | 2,893,138 |
| Jan 29, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.35 | $45.4K | 2,897,138 |
| Jan 27, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.69 | $42.8K | 2,901,138 |
| Jan 24, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.74 | $43.0K | 2,905,138 |
| Jan 21, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.72 | $42.9K | 2,909,138 |
| Jan 16, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.62 | $42.5K | 2,913,138 |
| Jan 14, 2025 | Ma Songjiang | President | Sell | 1,113 | $10.02 | $11.2K | 2,915,194 |
| Jan 8, 2025 | Ma Songjiang | President | Sell | 2,216 | $10.08 | $22.3K | 2,917,526 |
| Jan 6, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.89 | $47.5K | 2,920,467 |
| Jan 2, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.40 | $49.6K | 2,924,467 |
| Dec 30, 2024 | Ma Songjiang | President | Sell | 4,000 | $12.64 | $50.6K | 2,928,823 |
| Dec 26, 2024 | Ma Songjiang | President | Sell | 4,000 | $12.10 | $48.4K | 2,932,763 |
| Dec 23, 2024 | Ma Songjiang | President | Sell | 4,000 | $10.86 | $43.4K | 2,936,467 |
| Dec 19, 2024 | Ma Songjiang | President | Sell | 4,000 | $11.21 | $44.9K | 2,941,255 |
| Jul 1, 2024 | USMAN NASSIM | Sell | 3,452 | $12.00 | $41.4K | 1,636-68% | |
| May 2, 2024 | USMAN NASSIM | Sell | 20,000 | $14.13 | $282.6K | 6,736-75% | |
| Apr 3, 2024 | USMAN NASSIM | Sell | 20,000 | $16.15 | $323.0K | 1,636-92% | |
| Mar 19, 2024 | USMAN NASSIM | Sell | 20,000 | $17.26 | $345.2K | 1,636-92% | |
| Aug 10, 2022 | Blouse Grant E. | Chief Scientific Officer | Buy | 3,250 | $0.47 | $1.5K | 9,417+53% |
| Aug 10, 2022 | Miller Seline E. | SVP Finance; Interim CFO & PAO | Buy | 3,250 | $0.47 | $1.5K | 6,500+100% |
Showing 1–50 of 57
1 / 2
GYRE Insider Buying Activity
The following table shows recent insider purchases of Gyre Therapeutics, Inc. (GYRE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 10, 2022 | Blouse Grant E. | Chief Scientific Officer | Buy | 3,250 | $0.47 | $1.5K | 9,417+53% |
| Aug 10, 2022 | Miller Seline E. | SVP Finance; Interim CFO & PAO | Buy | 3,250 | $0.47 | $1.5K | 6,500+100% |
GYRE Insider Selling Activity
The following table shows recent insider sales of Gyre Therapeutics, Inc. (GYRE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 20,918 | $6.16 | $128.9K | 700,000 |
| Jun 8, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 34,976 | $6.25 | $218.6K | 700,000 |
| May 27, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 7,500 | $6.09 | $45.7K | 700,000 |
| May 22, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 12,820 | $6.15 | $78.8K | 700,000 |
| May 20, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 9,320 | $6.38 | $59.4K | 700,000 |
| May 18, 2026 | Ye Weiguo | officer: Chief Operating Officer | Sell | 28,680 | $6.79 | $194.8K | 700,000 |
| May 7, 2026 | Luo Ying | director, officer: Chief Executive Officer | Sell | 10,315 | $8.04 | $82.9K | 2,575,362 |
| May 27, 2025 | Ma Songjiang | President | Sell | 2,558 | $10.23 | $26.2K | 0 |
| May 22, 2025 | Ma Songjiang | President | Sell | 2,182 | $10.91 | $23.8K | 0 |
| May 20, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.04 | $44.2K | 0 |
| May 16, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.21 | $44.8K | 0 |
| May 14, 2025 | Ma Songjiang | President | Sell | 2,020 | $10.69 | $21.6K | 0 |
| May 12, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.97 | $43.9K | 0 |
| Mar 21, 2025 | Ma Songjiang | President | Sell | 174 | $10.00 | $1.7K | 0 |
| Mar 19, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.11 | $40.4K | 0 |
| Mar 17, 2025 | Ma Songjiang | President | Sell | 2,242 | $11.89 | $26.7K | 0 |
| Mar 13, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.06 | $48.2K | 0 |
| Mar 11, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.57 | $46.3K | 0 |
| Mar 7, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.19 | $40.8K | 0 |
| Mar 5, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.89 | $43.6K | 0 |
| Mar 3, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.05 | $44.2K | 0 |
| Feb 27, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.37 | $45.5K | 0 |
| Feb 25, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.50 | $46.0K | 0 |
| Feb 21, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.30 | $45.2K | 0 |
| Feb 19, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.22 | $48.9K | 2,869,260 |
| Feb 14, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.59 | $46.4K | 2,873,260 |
| Feb 12, 2025 | Ma Songjiang | President | Sell | 3,878 | $11.72 | $45.4K | 2,877,138 |
| Feb 11, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.51 | $50.0K | 2,881,138 |
| Feb 6, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.01 | $48.0K | 2,885,138 |
| Feb 4, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.49 | $46.0K | 2,889,138 |
| Jan 31, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.40 | $45.6K | 2,893,138 |
| Jan 29, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.35 | $45.4K | 2,897,138 |
| Jan 27, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.69 | $42.8K | 2,901,138 |
| Jan 24, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.74 | $43.0K | 2,905,138 |
| Jan 21, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.72 | $42.9K | 2,909,138 |
| Jan 16, 2025 | Ma Songjiang | President | Sell | 4,000 | $10.62 | $42.5K | 2,913,138 |
| Jan 14, 2025 | Ma Songjiang | President | Sell | 1,113 | $10.02 | $11.2K | 2,915,194 |
| Jan 8, 2025 | Ma Songjiang | President | Sell | 2,216 | $10.08 | $22.3K | 2,917,526 |
| Jan 6, 2025 | Ma Songjiang | President | Sell | 4,000 | $11.89 | $47.5K | 2,920,467 |
| Jan 2, 2025 | Ma Songjiang | President | Sell | 4,000 | $12.40 | $49.6K | 2,924,467 |
| Dec 30, 2024 | Ma Songjiang | President | Sell | 4,000 | $12.64 | $50.6K | 2,928,823 |
| Dec 26, 2024 | Ma Songjiang | President | Sell | 4,000 | $12.10 | $48.4K | 2,932,763 |
| Dec 23, 2024 | Ma Songjiang | President | Sell | 4,000 | $10.86 | $43.4K | 2,936,467 |
| Dec 19, 2024 | Ma Songjiang | President | Sell | 4,000 | $11.21 | $44.9K | 2,941,255 |
| Jul 1, 2024 | USMAN NASSIM | Sell | 3,452 | $12.00 | $41.4K | 1,636-68% | |
| May 2, 2024 | USMAN NASSIM | Sell | 20,000 | $14.13 | $282.6K | 6,736-75% | |
| Apr 3, 2024 | USMAN NASSIM | Sell | 20,000 | $16.15 | $323.0K | 1,636-92% | |
| Mar 19, 2024 | USMAN NASSIM | Sell | 20,000 | $17.26 | $345.2K | 1,636-92% |
GYRE Insiders
Similar Stocks to GYRE
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B